Videos

Sameera Kumar, MD, highlights the role radiation plays in the treatment of patients with stage 3 non-small cell lung cancer.

William Grady, MD, compares biomarker-based testing and colonoscopy when considering options for colorectal cancer screening.

Estelamari Rodriguez, MD, MPH, assesses the potential of CTLA-4 inhibitors in the first-line setting for patients with non-small cell lung cancer.

Deborah Doroshow, MD, PhD, discusses the role of immunotherapy when treating patients with small cell lung cancer.

Ian Tobal, DO, discusses an analysis of real-world Child-Pugh score and outcomes among patients undergoing treatment for hepatocellular carcinoma.

Reid Ness, MD, MPH, discusses the nordICC trial, which assessed the efficacy of using colonoscopy as a primary screening tool.

Vivek Subbiah, MD, discusses advances in tumor agnostic therapies and explores how these therapies can shift the treatment landscape for patients with solid tumors.

Reid Ness, MD, MPH, argues that colonoscopy is superior compared to biomarker-based testing for the detection of colorectal cancer.

Shipra Gandhi, MD, makes the case against moving novel endocrine backbones to earlier lines of therapy in breast cancer.

Raghav Sundar, MD, PhD, discusses the importance of considering tumor biology and anatomic site when determining treatments for patients with gastrointestinal cancers.